ISELIN, N.J., Nov. 2 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced today that Robert P. Hickey, President and CEO, will present at the ACUMEN BioFin 9th Annual Healthcare Conference on November 5, 2007 at 5:05 PM, EDT, at the New York Palace Hotel in New York City. Mr. Hickey will present a company overview.
The presentation will be available via web cast for 90 days, beginning on November 5, 2007, and can be viewed by clicking on the following link: http://www.wsw.com/webcast/rrshq12/symd.ob
About SyntheMed, Inc.
SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products. The Company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.
Statements in this Press Release that are not statements of historical fact, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 for a description of these, as well as other, risks and uncertainties.
|SOURCE SyntheMed, Inc.|
Copyright©2007 PR Newswire.
All rights reserved